These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31970786)

  • 21. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
    Payandeh M; Shahriari-Ahmadi A; Sadeghi M; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(3):1015-8. PubMed ID: 27039719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth.
    Yan F; Wang X; Zhu M; Hu X
    Oncol Rep; 2016 Nov; 36(5):2793-2799. PubMed ID: 27666310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression.
    Mylonis I; Sembongi H; Befani C; Liakos P; Siniossoglou S; Simos G
    J Cell Sci; 2012 Jul; 125(Pt 14):3485-93. PubMed ID: 22467849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
    Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
    J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
    Pu Q; Lv YR; Dong K; Geng WW; Gao HD
    BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipin-1 expression is critical for keratinocyte differentiation.
    Chae M; Jung JY; Bae IH; Kim HJ; Lee TR; Shin DW
    J Lipid Res; 2016 Apr; 57(4):563-73. PubMed ID: 26658689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.
    Allred DC; Clark GM; Elledge R; Fuqua SA; Brown RW; Chamness GC; Osborne CK; McGuire WL
    J Natl Cancer Inst; 1993 Feb; 85(3):200-6. PubMed ID: 8423624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
    Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
    Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
    J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional role of RRS1 in breast cancer cell proliferation.
    Song J; Ma Z; Hua Y; Xu J; Li N; Ju C; Hou L
    J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
    Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
    Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients.
    Ozretic P; Alvir I; Sarcevic B; Vujaskovic Z; Rendic-Miocevic Z; Roguljic A; Beketic-Oreskovic L
    Int J Biol Markers; 2018 Jan; 33(1):109-115. PubMed ID: 28777433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.